BioXcel Therapeutics (BTAI) FCF Margin (QoQ) (2022 - 2026)
BioXcel Therapeutics (BTAI) FCF Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | BioXcel Therapeutics | 20.49 Mn | 20.49 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18,174.00 |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | -869,124.00 |
| Jun 30, 2025 | -331,071.00 |
| Mar 31, 2025 | -312,228.00 |
| Dec 31, 2024 | 358,840.00 |
| Sep 30, 2024 | -553,549.00 |
| Jun 30, 2024 | 94,317.00 |
| Mar 31, 2024 | 410,215.00 |
| Dec 31, 2023 | 387,729.00 |
| Sep 30, 2023 | -266,153.00 |
| Jun 30, 2023 | 1.71 Mn |
| Mar 31, 2023 | -917,920.00 |
| Dec 31, 2022 | 652,863.00 |